# IN VITRO TESTING IN HUMAN CELL LINES FOR ANTIMICROBIAL ACTIVITY AGAINST SARS-COV-2

> **NIH NIH N02** · UNIVERSITY OF PENNSYLVANIA · 2021 · $971,739

## Abstract

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.

## Key facts

- **NIH application ID:** 10409305
- **Project number:** 75N93021P00602-0-0-1
- **Recipient organization:** UNIVERSITY OF PENNSYLVANIA
- **Principal Investigator:** SARA CHERRY
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $971,739
- **Award type:** —
- **Project period:** 2021-05-03 → 2022-05-02

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10409305

## Citation

> US National Institutes of Health, RePORTER application 10409305, IN VITRO TESTING IN HUMAN CELL LINES FOR ANTIMICROBIAL ACTIVITY AGAINST SARS-COV-2 (75N93021P00602-0-0-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10409305. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*